AGER and myocardial infarction: Extracellular receptor-interacting protein kinase 3 (RIPK3), which promotes necroptosis when intracellular, was recognized as a DAMP which activates receptor for advanced glycation end products (RAGE) in myocardial infarction and reperfusion injury in 2024 (23).